Rb1NRF2-PPARγ-ACSL4,PTECs

Binghong Tan1, Zhifen Wu1, Suwei Wang1

  • 1Department of Nephrology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.

Chinese medicine
|January 8, 2026
PubMed
概括

金色化物Rb1 (Rb1) 通过抑制铁化,有效地治疗急性损伤 (AKI),其性能优于费罗斯塔丁-1. Rb1激活NRF2-PPARγ-ACSL4通路,为AKI提供了一个有前途的治疗策略.